Gyre Therapeutics (GYRE) Payables (2016 - 2025)
Historic Payables for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to $556000.0.
- Gyre Therapeutics' Payables rose 8349.83% to $556000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $556000.0, marking a year-over-year increase of 8349.83%. This contributed to the annual value of $108000.0 for FY2024, which is 6957.75% down from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Payables is $556000.0, which was up 8349.83% from $71000.0 recorded in Q2 2025.
- Gyre Therapeutics' Payables' 5-year high stood at $7.7 million during Q4 2022, with a 5-year trough of $5000.0 in Q2 2023.
- In the last 5 years, Gyre Therapeutics' Payables had a median value of $330000.0 in 2024 and averaged $1.6 million.
- As far as peak fluctuations go, Gyre Therapeutics' Payables tumbled by 9966.0% in 2023, and later skyrocketed by 532000.0% in 2024.
- Gyre Therapeutics' Payables (Quarter) stood at $6.4 million in 2021, then rose by 19.64% to $7.7 million in 2022, then tumbled by 95.38% to $355000.0 in 2023, then crashed by 69.58% to $108000.0 in 2024, then soared by 414.81% to $556000.0 in 2025.
- Its Payables was $556000.0 in Q3 2025, compared to $71000.0 in Q2 2025 and $122000.0 in Q1 2025.